

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of clathrin-mediated endocytosis (GO:2000369) | 9.32883118 |
| 2 | positive regulation of antigen processing and presentation (GO:0002579) | 8.74675025 |
| 3 | regulation of acrosome reaction (GO:0060046) | 7.66226650 |
| 4 | fusion of sperm to egg plasma membrane (GO:0007342) | 7.05819023 |
| 5 | regulation of antigen processing and presentation (GO:0002577) | 7.05376666 |
| 6 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 6.43489765 |
| 7 | complement activation, alternative pathway (GO:0006957) | 5.87500777 |
| 8 | plasma membrane fusion (GO:0045026) | 5.39913328 |
| 9 | macroautophagy (GO:0016236) | 5.15429704 |
| 10 | sulfur amino acid catabolic process (GO:0000098) | 4.89616618 |
| 11 | regulation of Cdc42 GTPase activity (GO:0043088) | 4.56908432 |
| 12 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.38255430 |
| 13 | valine metabolic process (GO:0006573) | 4.10257363 |
| 14 | regulation of hydrogen peroxide metabolic process (GO:0010310) | 3.94654085 |
| 15 | alpha-linolenic acid metabolic process (GO:0036109) | 3.76453389 |
| 16 | GPI anchor biosynthetic process (GO:0006506) | 3.75519531 |
| 17 | response to misfolded protein (GO:0051788) | 3.72534415 |
| 18 | GPI anchor metabolic process (GO:0006505) | 3.49761360 |
| 19 | low-density lipoprotein particle clearance (GO:0034383) | 3.44522939 |
| 20 | cellular sodium ion homeostasis (GO:0006883) | 3.35399065 |
| 21 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 3.33505854 |
| 22 | cytolysis (GO:0019835) | 3.32722250 |
| 23 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 3.30731186 |
| 24 | negative regulation of endocytosis (GO:0045806) | 3.26393343 |
| 25 | regulation of complement activation (GO:0030449) | 3.25255159 |
| 26 | triglyceride catabolic process (GO:0019433) | 3.18790417 |
| 27 | negative regulation of metanephros development (GO:0072217) | 3.15646779 |
| 28 | mannose metabolic process (GO:0006013) | 3.13802972 |
| 29 | brown fat cell differentiation (GO:0050873) | 3.13312154 |
| 30 | response to nitrosative stress (GO:0051409) | 3.11867814 |
| 31 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.11146892 |
| 32 | positive regulation of response to oxidative stress (GO:1902884) | 3.11146892 |
| 33 | regulation of epithelial cell differentiation involved in kidney development (GO:2000696) | 3.09178836 |
| 34 | regulation of protein activation cascade (GO:2000257) | 3.07712700 |
| 35 | neutral lipid catabolic process (GO:0046461) | 2.98703445 |
| 36 | acylglycerol catabolic process (GO:0046464) | 2.98703445 |
| 37 | phospholipid homeostasis (GO:0055091) | 2.98445558 |
| 38 | ethanol oxidation (GO:0006069) | 2.98243019 |
| 39 | white fat cell differentiation (GO:0050872) | 2.96989662 |
| 40 | misfolded or incompletely synthesized protein catabolic process (GO:0006515) | 2.93371567 |
| 41 | xenobiotic catabolic process (GO:0042178) | 2.91336060 |
| 42 | respiratory burst (GO:0045730) | 2.90884762 |
| 43 | positive regulation of receptor biosynthetic process (GO:0010870) | 2.85611538 |
| 44 | positive regulation of sterol transport (GO:0032373) | 2.75489886 |
| 45 | positive regulation of cholesterol transport (GO:0032376) | 2.75489886 |
| 46 | oxaloacetate metabolic process (GO:0006107) | 2.74890743 |
| 47 | L-serine metabolic process (GO:0006563) | 2.72169208 |
| 48 | regulation of nephron tubule epithelial cell differentiation (GO:0072182) | 2.67845158 |
| 49 | COPI coating of Golgi vesicle (GO:0048205) | 2.66133600 |
| 50 | Golgi transport vesicle coating (GO:0048200) | 2.66133600 |
| 51 | positive regulation of glomerulus development (GO:0090193) | 2.64178765 |
| 52 | negative regulation of protein autophosphorylation (GO:0031953) | 2.60805264 |
| 53 | cysteine metabolic process (GO:0006534) | 2.58530109 |
| 54 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:004316 | 2.57083972 |
| 55 | * negative regulation of endopeptidase activity (GO:0010951) | 2.56893321 |
| 56 | metanephric nephron tubule development (GO:0072234) | 2.48507059 |
| 57 | metanephric tubule development (GO:0072170) | 2.48507059 |
| 58 | L-serine transport (GO:0015825) | 2.47469422 |
| 59 | sodium ion homeostasis (GO:0055078) | 2.46215862 |
| 60 | * negative regulation of peptidase activity (GO:0010466) | 2.44974040 |
| 61 | regulation of lipoprotein metabolic process (GO:0050746) | 2.44299271 |
| 62 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.43400958 |
| 63 | regulation of cholesterol transport (GO:0032374) | 2.42220246 |
| 64 | regulation of sterol transport (GO:0032371) | 2.42220246 |
| 65 | CDP-diacylglycerol biosynthetic process (GO:0016024) | 2.41982341 |
| 66 | epithelial cell differentiation involved in kidney development (GO:0035850) | 2.41933063 |
| 67 | glycerolipid catabolic process (GO:0046503) | 2.41049101 |
| 68 | fatty acid beta-oxidation (GO:0006635) | 2.39234412 |
| 69 | nerve growth factor signaling pathway (GO:0038180) | 2.37944256 |
| 70 | regulation of receptor biosynthetic process (GO:0010869) | 2.35755368 |
| 71 | regulation of bile acid biosynthetic process (GO:0070857) | 2.35547621 |
| 72 | triglyceride biosynthetic process (GO:0019432) | 2.31148121 |
| 73 | negative regulation of lipase activity (GO:0060192) | 2.29420151 |
| 74 | cellular modified amino acid catabolic process (GO:0042219) | 2.28388777 |
| 75 | metanephric nephron epithelium development (GO:0072243) | 2.27399820 |
| 76 | branched-chain amino acid metabolic process (GO:0009081) | 2.23625300 |
| 77 | 2-oxoglutarate metabolic process (GO:0006103) | 2.22749025 |
| 78 | regulation of response to reactive oxygen species (GO:1901031) | 2.22257605 |
| 79 | CDP-diacylglycerol metabolic process (GO:0046341) | 2.21945886 |
| 80 | eye photoreceptor cell differentiation (GO:0001754) | 2.21379293 |
| 81 | photoreceptor cell differentiation (GO:0046530) | 2.21379293 |
| 82 | transcytosis (GO:0045056) | 2.20324881 |
| 83 | complement activation (GO:0006956) | 2.20270781 |
| 84 | positive regulation of fatty acid metabolic process (GO:0045923) | 2.20094414 |
| 85 | collecting duct development (GO:0072044) | 2.19792932 |
| 86 | acylglycerol biosynthetic process (GO:0046463) | 2.17813731 |
| 87 | neutral lipid biosynthetic process (GO:0046460) | 2.17813731 |
| 88 | positive regulation of receptor recycling (GO:0001921) | 2.16734176 |
| 89 | carnitine transmembrane transport (GO:1902603) | 2.15598610 |
| 90 | serine transport (GO:0032329) | 2.15141307 |
| 91 | kynurenine metabolic process (GO:0070189) | 2.15061321 |
| 92 | high-density lipoprotein particle remodeling (GO:0034375) | 2.14545957 |
| 93 | complement activation, classical pathway (GO:0006958) | 2.13648016 |
| 94 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.11662158 |
| 95 | toxin transport (GO:1901998) | 2.11130814 |
| 96 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 19.2447708 |
| 97 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 19.2447708 |
| 98 | antigen processing and presentation via MHC class Ib (GO:0002475) | 18.1574724 |
| 99 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 17.1260819 |
| 100 | antigen processing and presentation of endogenous antigen (GO:0019883) | 16.0704775 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.31778745 |
| 2 | IGF1R_20145208_ChIP-Seq_DFB_Human | 3.69292344 |
| 3 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.76567094 |
| 4 | AR_21572438_ChIP-Seq_LNCaP_Human | 2.76229328 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.70415938 |
| 6 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 2.61851740 |
| 7 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.42571692 |
| 8 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.26729728 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.24326824 |
| 10 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.15822492 |
| 11 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.06388667 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 12.2987037 |
| 13 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.84373643 |
| 14 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.74257009 |
| 15 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.64004822 |
| 16 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.58336615 |
| 17 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.54758115 |
| 18 | MYC_19915707_ChIP-ChIP_AK7_Human | 1.39841952 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.39797478 |
| 20 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.38377129 |
| 21 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.37330727 |
| 22 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.33350771 |
| 23 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.32249902 |
| 24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.28775919 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.27376870 |
| 26 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24294130 |
| 27 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24136682 |
| 28 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.23482907 |
| 29 | ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.23325142 |
| 30 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.23007716 |
| 31 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 1.22471911 |
| 32 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.18138715 |
| 33 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.17920455 |
| 34 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.17100658 |
| 35 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.15404916 |
| 36 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.15190162 |
| 37 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.14773448 |
| 38 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.12065935 |
| 39 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.10678908 |
| 40 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.09618481 |
| 41 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.09223462 |
| 42 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.08947069 |
| 43 | STAT1_17558387_ChIP-Seq_HELA_Human | 1.07113290 |
| 44 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.06917383 |
| 45 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.05385470 |
| 46 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05374550 |
| 47 | KAP1_22055183_ChIP-Seq_ESCs_Mouse | 1.04789889 |
| 48 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.03312019 |
| 49 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.03312019 |
| 50 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.02903630 |
| 51 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00415534 |
| 52 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 0.97774105 |
| 53 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95407309 |
| 54 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93663400 |
| 55 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93663400 |
| 56 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.92679896 |
| 57 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.92010117 |
| 58 | * AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.90242266 |
| 59 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 0.89004666 |
| 60 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.88357958 |
| 61 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.87631303 |
| 62 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.87370839 |
| 63 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 0.87083510 |
| 64 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 0.86008058 |
| 65 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.85930427 |
| 66 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85418088 |
| 67 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.83643256 |
| 68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.82605518 |
| 69 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.81994175 |
| 70 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81356818 |
| 71 | KDM2B_26808549_Chip-Seq_K562_Human | 0.81058565 |
| 72 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.79829063 |
| 73 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.79613749 |
| 74 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.79277850 |
| 75 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.79033028 |
| 76 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.78877373 |
| 77 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.78118909 |
| 78 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.77873007 |
| 79 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.77851850 |
| 80 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.77791774 |
| 81 | GATA1_19941826_ChIP-Seq_K562_Human | 0.77783751 |
| 82 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.77559613 |
| 83 | OCT1_27270436_Chip-Seq_PROSTATE_Human | 0.76866182 |
| 84 | CEBPB_26923725_Chip-Seq_MESODERM_Mouse | 0.76548818 |
| 85 | GATA2_19941826_ChIP-Seq_K562_Human | 0.76455048 |
| 86 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.75597431 |
| 87 | * CEBPB_22108803_ChIP-Seq_LS180_Human | 0.74132125 |
| 88 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.73828179 |
| 89 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.73506578 |
| 90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.73068241 |
| 91 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.72974646 |
| 92 | * FOXA1_27270436_Chip-Seq_PROSTATE_Human | 0.72895295 |
| 93 | * FOXA1_25329375_ChIP-Seq_VCAP_Human | 0.72895295 |
| 94 | FLI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.72523951 |
| 95 | * CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.72501820 |
| 96 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.71961313 |
| 97 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.70943427 |
| 98 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.70668424 |
| 99 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.70417482 |
| 100 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.70373885 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 6.24513738 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.32379203 |
| 3 | MP0005670_abnormal_white_adipose | 3.77306873 |
| 4 | MP0003705_abnormal_hypodermis_morpholog | 3.00706497 |
| 5 | MP0003195_calcinosis | 2.95596598 |
| 6 | MP0005666_abnormal_adipose_tissue | 2.67026715 |
| 7 | MP0008438_abnormal_cutaneous_collagen | 2.62214014 |
| 8 | MP0010329_abnormal_lipoprotein_level | 2.62203642 |
| 9 | MP0004130_abnormal_muscle_cell | 2.60302224 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.50707164 |
| 11 | MP0005375_adipose_tissue_phenotype | 2.42645936 |
| 12 | MP0005360_urolithiasis | 2.40074947 |
| 13 | MP0005365_abnormal_bile_salt | 2.32095736 |
| 14 | MP0004185_abnormal_adipocyte_glucose | 2.18107070 |
| 15 | MP0002254_reproductive_system_inflammat | 2.13027480 |
| 16 | MP0003300_gastrointestinal_ulcer | 2.12405627 |
| 17 | MP0000003_abnormal_adipose_tissue | 2.11555500 |
| 18 | MP0002876_abnormal_thyroid_physiology | 1.92384671 |
| 19 | MP0003806_abnormal_nucleotide_metabolis | 1.89960589 |
| 20 | MP0002837_dystrophic_cardiac_calcinosis | 1.82719735 |
| 21 | MP0002118_abnormal_lipid_homeostasis | 1.81882610 |
| 22 | MP0003690_abnormal_glial_cell | 1.74362430 |
| 23 | MP0001501_abnormal_sleep_pattern | 1.72092875 |
| 24 | MP0005085_abnormal_gallbladder_physiolo | 1.70612025 |
| 25 | MP0004019_abnormal_vitamin_homeostasis | 1.67303561 |
| 26 | MP0005275_abnormal_skin_tensile | 1.59401392 |
| 27 | MP0004858_abnormal_nervous_system | 1.57938680 |
| 28 | MP0009763_increased_sensitivity_to | 1.56010382 |
| 29 | MP0010234_abnormal_vibrissa_follicle | 1.52788985 |
| 30 | MP0002138_abnormal_hepatobiliary_system | 1.52295370 |
| 31 | MP0009643_abnormal_urine_homeostasis | 1.47574595 |
| 32 | MP0003566_abnormal_cell_adhesion | 1.46223456 |
| 33 | MP0002971_abnormal_brown_adipose | 1.46146600 |
| 34 | MP0004272_abnormal_basement_membrane | 1.43935244 |
| 35 | MP0003075_altered_response_to | 1.43894011 |
| 36 | MP0009780_abnormal_chondrocyte_physiolo | 1.41474921 |
| 37 | MP0005332_abnormal_amino_acid | 1.40312090 |
| 38 | MP0003252_abnormal_bile_duct | 1.36591607 |
| 39 | MP0009115_abnormal_fat_cell | 1.36407607 |
| 40 | MP0000609_abnormal_liver_physiology | 1.34604338 |
| 41 | MP0005334_abnormal_fat_pad | 1.33295778 |
| 42 | MP0001756_abnormal_urination | 1.32293457 |
| 43 | MP0001765_abnormal_ion_homeostasis | 1.26817881 |
| 44 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.24682443 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.21692823 |
| 46 | MP0001764_abnormal_homeostasis | 1.16663273 |
| 47 | MP0000685_abnormal_immune_system | 1.16093810 |
| 48 | MP0008875_abnormal_xenobiotic_pharmacok | 1.15433322 |
| 49 | MP0003045_fibrosis | 1.14159889 |
| 50 | MP0005535_abnormal_body_temperature | 1.13142965 |
| 51 | MP0004043_abnormal_pH_regulation | 1.12204129 |
| 52 | MP0005636_abnormal_mineral_homeostasis | 1.07919276 |
| 53 | MP0008995_early_reproductive_senescence | 1.07055891 |
| 54 | MP0001666_abnormal_nutrient_absorption | 1.06002903 |
| 55 | MP0000751_myopathy | 1.02442946 |
| 56 | MP0000604_amyloidosis | 1.01260603 |
| 57 | MP0002909_abnormal_adrenal_gland | 1.01221248 |
| 58 | MP0002796_impaired_skin_barrier | 0.99027938 |
| 59 | MP0003186_abnormal_redox_activity | 0.98125242 |
| 60 | MP0003172_abnormal_lysosome_physiology | 0.97039771 |
| 61 | MP0000013_abnormal_adipose_tissue | 0.96862918 |
| 62 | MP0003959_abnormal_lean_body | 0.96858948 |
| 63 | MP0003950_abnormal_plasma_membrane | 0.95139789 |
| 64 | MP0002136_abnormal_kidney_physiology | 0.92094055 |
| 65 | MP0002295_abnormal_pulmonary_circulatio | 0.91267092 |
| 66 | MP0010386_abnormal_urinary_bladder | 0.89917119 |
| 67 | MP0000467_abnormal_esophagus_morphology | 0.87476135 |
| 68 | MP0004885_abnormal_endolymph | 0.87412254 |
| 69 | MP0005319_abnormal_enzyme/_coenzyme | 0.87256653 |
| 70 | MP0001177_atelectasis | 0.85925919 |
| 71 | MP0002078_abnormal_glucose_homeostasis | 0.85316723 |
| 72 | MP0002970_abnormal_white_adipose | 0.84937599 |
| 73 | MP0003283_abnormal_digestive_organ | 0.82620458 |
| 74 | MP0004947_skin_inflammation | 0.82429958 |
| 75 | MP0004264_abnormal_extraembryonic_tissu | 0.81429161 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 0.81411341 |
| 77 | MP0008004_abnormal_stomach_pH | 0.81068171 |
| 78 | MP0001958_emphysema | 0.80135966 |
| 79 | MP0005448_abnormal_energy_balance | 0.79453443 |
| 80 | MP0001533_abnormal_skeleton_physiology | 0.79332391 |
| 81 | MP0002693_abnormal_pancreas_physiology | 0.79283228 |
| 82 | MP0003879_abnormal_hair_cell | 0.78963309 |
| 83 | MP0002234_abnormal_pharynx_morphology | 0.77937782 |
| 84 | MP0005377_hearing/vestibular/ear_phenot | 0.77491283 |
| 85 | MP0003878_abnormal_ear_physiology | 0.77491283 |
| 86 | MP0001661_extended_life_span | 0.77070522 |
| 87 | MP0006138_congestive_heart_failure | 0.76495973 |
| 88 | MP0001853_heart_inflammation | 0.76309073 |
| 89 | MP0002168_other_aberrant_phenotype | 0.76074635 |
| 90 | MP0010352_gastrointestinal_tract_polyps | 0.73994835 |
| 91 | MP0005164_abnormal_response_to | 0.73855300 |
| 92 | MP0000230_abnormal_systemic_arterial | 0.71171547 |
| 93 | MP0003724_increased_susceptibility_to | 0.69992387 |
| 94 | MP0003329_amyloid_beta_deposits | 0.66378810 |
| 95 | MP0003183_abnormal_peptide_metabolism | 0.65727922 |
| 96 | MP0008872_abnormal_physiological_respon | 0.65343589 |
| 97 | MP0002229_neurodegeneration | 0.64016108 |
| 98 | MP0008961_abnormal_basal_metabolism | 0.63569019 |
| 99 | MP0004270_analgesia | 0.62819639 |
| 100 | MP0008775_abnormal_heart_ventricle | 0.62796447 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Choroideremia (HP:0001139) | 8.17971947 |
| 2 | Abnormality of the fovea (HP:0000493) | 7.24867800 |
| 3 | Complement deficiency (HP:0004431) | 6.74100266 |
| 4 | Abnormal rod and cone electroretinograms (HP:0008323) | 6.51667851 |
| 5 | Vacuolated lymphocytes (HP:0001922) | 6.39267343 |
| 6 | Bony spicule pigmentary retinopathy (HP:0007737) | 5.53655425 |
| 7 | Hand muscle atrophy (HP:0009130) | 5.08604430 |
| 8 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.90374640 |
| 9 | Abnormality of complement system (HP:0005339) | 4.89951182 |
| 10 | 11 pairs of ribs (HP:0000878) | 4.74228867 |
| 11 | Metaphyseal cupping (HP:0003021) | 4.58293609 |
| 12 | Hypopigmentation of the fundus (HP:0007894) | 4.57100097 |
| 13 | Action tremor (HP:0002345) | 4.40199271 |
| 14 | Stridor (HP:0010307) | 4.28820357 |
| 15 | Upper limb amyotrophy (HP:0009129) | 4.24986389 |
| 16 | Distal upper limb amyotrophy (HP:0007149) | 4.24986389 |
| 17 | Facial diplegia (HP:0001349) | 3.83026405 |
| 18 | Diaphragmatic weakness (HP:0009113) | 3.80681044 |
| 19 | Vascular calcification (HP:0004934) | 3.76432567 |
| 20 | Neurofibrillary tangles (HP:0002185) | 3.72596072 |
| 21 | Potter facies (HP:0002009) | 3.68055107 |
| 22 | Facial shape deformation (HP:0011334) | 3.68055107 |
| 23 | Cardiovascular calcification (HP:0011915) | 3.52192731 |
| 24 | Missing ribs (HP:0000921) | 3.43028970 |
| 25 | Intention tremor (HP:0002080) | 3.42311651 |
| 26 | Cerebral inclusion bodies (HP:0100314) | 3.40215605 |
| 27 | Hyperglycinuria (HP:0003108) | 3.25955150 |
| 28 | Abnormality of the calcaneus (HP:0008364) | 3.16405237 |
| 29 | Hyperphosphatemia (HP:0002905) | 3.15706284 |
| 30 | Dysostosis multiplex (HP:0000943) | 3.04389449 |
| 31 | Clumsiness (HP:0002312) | 2.91224111 |
| 32 | Hyperglycinemia (HP:0002154) | 2.86230491 |
| 33 | Abnormality of glycine metabolism (HP:0010895) | 2.77478675 |
| 34 | Abnormality of serine family amino acid metabolism (HP:0010894) | 2.77478675 |
| 35 | Myocardial infarction (HP:0001658) | 2.77068985 |
| 36 | Ankle clonus (HP:0011448) | 2.76846553 |
| 37 | Myopathic facies (HP:0002058) | 2.67129093 |
| 38 | Infantile muscular hypotonia (HP:0008947) | 2.65999295 |
| 39 | Hypoventilation (HP:0002791) | 2.59687859 |
| 40 | Tubulointerstitial fibrosis (HP:0005576) | 2.54081100 |
| 41 | Oligomenorrhea (HP:0000876) | 2.53670717 |
| 42 | Nonprogressive disorder (HP:0003680) | 2.50936163 |
| 43 | Abnormality of macular pigmentation (HP:0008002) | 2.47604165 |
| 44 | Ketoacidosis (HP:0001993) | 2.42159096 |
| 45 | Agitation (HP:0000713) | 2.41882750 |
| 46 | Hemiplegia (HP:0002301) | 2.38530285 |
| 47 | Abnormality of the vocal cords (HP:0008777) | 2.36477669 |
| 48 | Abnormality of macrophages (HP:0004311) | 2.34899942 |
| 49 | Hypertriglyceridemia (HP:0002155) | 2.34356693 |
| 50 | Tongue fasciculations (HP:0001308) | 2.33929924 |
| 51 | Proximal tubulopathy (HP:0000114) | 2.32102220 |
| 52 | Cervical subluxation (HP:0003308) | 2.29427557 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.28911667 |
| 54 | Central scotoma (HP:0000603) | 2.27681354 |
| 55 | Muscle fibrillation (HP:0010546) | 2.26598776 |
| 56 | Acanthosis nigricans (HP:0000956) | 2.20688604 |
| 57 | Abnormality of the musculature of the hand (HP:0001421) | 2.20155281 |
| 58 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.12954798 |
| 59 | Mucopolysacchariduria (HP:0008155) | 2.12954798 |
| 60 | Focal segmental glomerulosclerosis (HP:0000097) | 2.09148077 |
| 61 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.08820187 |
| 62 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.08820187 |
| 63 | Ectopia lentis (HP:0001083) | 2.07197755 |
| 64 | Systemic lupus erythematosus (HP:0002725) | 2.07195986 |
| 65 | Hypophosphatemic rickets (HP:0004912) | 2.03153168 |
| 66 | Skin nodule (HP:0200036) | 2.00947275 |
| 67 | Subcapsular cataract (HP:0000523) | 2.00214462 |
| 68 | Abnormality of the lumbar spine (HP:0100712) | 1.99071583 |
| 69 | Abnormality of purine metabolism (HP:0004352) | 1.98875984 |
| 70 | Loss of speech (HP:0002371) | 1.94652366 |
| 71 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.93991760 |
| 72 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.93991760 |
| 73 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.93991760 |
| 74 | Restlessness (HP:0000711) | 1.90763784 |
| 75 | Thin ribs (HP:0000883) | 1.88768924 |
| 76 | Pseudobulbar signs (HP:0002200) | 1.83781029 |
| 77 | Ketosis (HP:0001946) | 1.81604042 |
| 78 | Hemorrhage of the eye (HP:0011885) | 1.79846618 |
| 79 | Osteomalacia (HP:0002749) | 1.78474019 |
| 80 | Polar cataract (HP:0010696) | 1.76883276 |
| 81 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.76083013 |
| 82 | Growth hormone excess (HP:0000845) | 1.74469910 |
| 83 | Deep venous thrombosis (HP:0002625) | 1.72527347 |
| 84 | Glomerulosclerosis (HP:0000096) | 1.71451525 |
| 85 | Asymmetric growth (HP:0100555) | 1.71314053 |
| 86 | Myokymia (HP:0002411) | 1.69087678 |
| 87 | Thin bony cortex (HP:0002753) | 1.68051505 |
| 88 | Xanthomatosis (HP:0000991) | 1.67859899 |
| 89 | Beaking of vertebral bodies (HP:0004568) | 1.67593482 |
| 90 | Spondylolisthesis (HP:0003302) | 1.67024007 |
| 91 | Mutism (HP:0002300) | 1.66763832 |
| 92 | Cone-rod dystrophy (HP:0000548) | 1.66084594 |
| 93 | Abnormal hemoglobin (HP:0011902) | 1.64361697 |
| 94 | Aortic aneurysm (HP:0004942) | 1.63386769 |
| 95 | Cardiomegaly (HP:0001640) | 1.63265739 |
| 96 | Thyroid-stimulating hormone excess (HP:0002925) | 1.60004235 |
| 97 | Clonus (HP:0002169) | 1.58248535 |
| 98 | Right ventricular cardiomyopathy (HP:0011663) | 1.57595750 |
| 99 | Progressive visual loss (HP:0000529) | 1.56831210 |
| 100 | Intrahepatic cholestasis (HP:0001406) | 1.52700788 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 3.97036916 |
| 2 | SIK1 | 3.89410295 |
| 3 | TAOK3 | 3.88779196 |
| 4 | WNK4 | 3.00506187 |
| 5 | LMTK2 | 2.97017120 |
| 6 | MYLK | 2.51606165 |
| 7 | ERN1 | 2.42994187 |
| 8 | RIPK4 | 2.34301287 |
| 9 | PKN2 | 2.32695886 |
| 10 | RIPK1 | 2.30467153 |
| 11 | BMX | 1.93976907 |
| 12 | PRKD3 | 1.93426440 |
| 13 | FRK | 1.82882835 |
| 14 | CAMK1D | 1.81525873 |
| 15 | TTN | 1.79764171 |
| 16 | EPHB1 | 1.77502369 |
| 17 | INSRR | 1.71876549 |
| 18 | DDR2 | 1.65824626 |
| 19 | BCKDK | 1.60455337 |
| 20 | LRRK2 | 1.51015092 |
| 21 | WNK1 | 1.44158570 |
| 22 | MAP2K4 | 1.41508587 |
| 23 | RET | 1.35528517 |
| 24 | NTRK1 | 1.35227601 |
| 25 | MAP3K4 | 1.34727124 |
| 26 | PDGFRA | 1.34273159 |
| 27 | IRAK2 | 1.28820945 |
| 28 | CAMK1G | 1.27945640 |
| 29 | FER | 1.24629239 |
| 30 | MST4 | 1.23242620 |
| 31 | PAK3 | 1.22393508 |
| 32 | FLT3 | 1.20346233 |
| 33 | IRAK3 | 1.18072272 |
| 34 | AKT3 | 1.17720881 |
| 35 | PTK2 | 1.10718346 |
| 36 | PAK2 | 1.09945000 |
| 37 | LATS1 | 1.08053320 |
| 38 | PRKCH | 1.04959336 |
| 39 | PTK6 | 1.02778915 |
| 40 | GRK6 | 1.01634177 |
| 41 | FGFR4 | 1.01340301 |
| 42 | JAK2 | 0.98881635 |
| 43 | IRAK1 | 0.93761767 |
| 44 | MST1R | 0.93608901 |
| 45 | MET | 0.91761301 |
| 46 | MAP3K2 | 0.88728454 |
| 47 | JAK1 | 0.85277128 |
| 48 | EPHB2 | 0.82288760 |
| 49 | EGFR | 0.79275602 |
| 50 | STK38L | 0.75189601 |
| 51 | PHKG2 | 0.73863073 |
| 52 | PHKG1 | 0.73863073 |
| 53 | FGFR2 | 0.71941569 |
| 54 | LATS2 | 0.71893704 |
| 55 | DAPK2 | 0.70711176 |
| 56 | MAP2K7 | 0.69414461 |
| 57 | PTK2B | 0.69115269 |
| 58 | SRC | 0.68834801 |
| 59 | PRKCZ | 0.66354244 |
| 60 | FYN | 0.64521031 |
| 61 | SGK1 | 0.61719746 |
| 62 | MATK | 0.60262722 |
| 63 | PDK2 | 0.55961747 |
| 64 | MAP2K1 | 0.55824721 |
| 65 | PIK3CG | 0.55008581 |
| 66 | JAK3 | 0.53879341 |
| 67 | NTRK3 | 0.53064135 |
| 68 | ERBB2 | 0.52377648 |
| 69 | ILK | 0.51669044 |
| 70 | SIK2 | 0.50084249 |
| 71 | EEF2K | 0.49983489 |
| 72 | PDPK1 | 0.48545519 |
| 73 | MAP3K14 | 0.48324992 |
| 74 | GRK5 | 0.46302548 |
| 75 | KSR2 | 0.46195656 |
| 76 | STK38 | 0.46164683 |
| 77 | DAPK1 | 0.45275415 |
| 78 | PDK1 | 0.44669872 |
| 79 | PAK6 | 0.43651139 |
| 80 | CDK5 | 0.43568881 |
| 81 | SCYL2 | 0.42995429 |
| 82 | EPHA3 | 0.42720895 |
| 83 | PRKACG | 0.42225766 |
| 84 | PRKCG | 0.41893149 |
| 85 | MAP3K6 | 0.41173394 |
| 86 | MINK1 | 0.41041780 |
| 87 | INSR | 0.40383848 |
| 88 | TYK2 | 0.39098667 |
| 89 | CDK19 | 0.39032180 |
| 90 | FGFR3 | 0.38575809 |
| 91 | TESK1 | 0.38521073 |
| 92 | CDC42BPA | 0.38442299 |
| 93 | DMPK | 0.37233381 |
| 94 | GSK3A | 0.37070427 |
| 95 | ALK | 0.36768623 |
| 96 | CAMKK1 | 0.36710349 |
| 97 | PDK4 | 0.36685062 |
| 98 | PDK3 | 0.36685062 |
| 99 | PRKD1 | 0.35688923 |
| 100 | IGF1R | 0.35406904 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 3.79762347 |
| 2 | ABC transporters_Homo sapiens_hsa02010 | 3.43249438 |
| 3 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.25172970 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.98962277 |
| 5 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.82366478 |
| 6 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.76336350 |
| 7 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.72415972 |
| 8 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.68264328 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.58034212 |
| 10 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.26181564 |
| 11 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.22904583 |
| 12 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 2.10132498 |
| 13 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.08342249 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.03866805 |
| 15 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.99544175 |
| 16 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.77354413 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.76193569 |
| 18 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.76047913 |
| 19 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.73432507 |
| 20 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.72446252 |
| 21 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.66880602 |
| 22 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.65608004 |
| 23 | Prion diseases_Homo sapiens_hsa05020 | 1.58588992 |
| 24 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.55275989 |
| 25 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.52738980 |
| 26 | Salivary secretion_Homo sapiens_hsa04970 | 1.41091080 |
| 27 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.37211983 |
| 28 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.36859139 |
| 29 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.32749646 |
| 30 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30328964 |
| 31 | Lysosome_Homo sapiens_hsa04142 | 1.29034481 |
| 32 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.28756771 |
| 33 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.18106693 |
| 34 | Carbon metabolism_Homo sapiens_hsa01200 | 1.16796553 |
| 35 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.11520908 |
| 36 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.08590203 |
| 37 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.07358145 |
| 38 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.06915628 |
| 39 | Peroxisome_Homo sapiens_hsa04146 | 1.01072850 |
| 40 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.96915127 |
| 41 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.94379903 |
| 42 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.92637968 |
| 43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.90714364 |
| 44 | Renin secretion_Homo sapiens_hsa04924 | 0.89261203 |
| 45 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.80482104 |
| 46 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.79416688 |
| 47 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.78305589 |
| 48 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.78090780 |
| 49 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.76328925 |
| 50 | Bile secretion_Homo sapiens_hsa04976 | 0.73767924 |
| 51 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.68155296 |
| 52 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.66820946 |
| 53 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.65892090 |
| 54 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.60670656 |
| 55 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.60227978 |
| 56 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.60032946 |
| 57 | Insulin resistance_Homo sapiens_hsa04931 | 0.57349648 |
| 58 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.53971561 |
| 59 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.51777553 |
| 60 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.51105857 |
| 61 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.50335552 |
| 62 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.49357871 |
| 63 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.48570010 |
| 64 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47741133 |
| 65 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.46182957 |
| 66 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.45744599 |
| 67 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.43021698 |
| 68 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.42762086 |
| 69 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.42511493 |
| 70 | Mineral absorption_Homo sapiens_hsa04978 | 0.39017736 |
| 71 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.38307452 |
| 72 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.38094665 |
| 73 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.37038755 |
| 74 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.36891850 |
| 75 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.36259579 |
| 76 | Pertussis_Homo sapiens_hsa05133 | 0.35999857 |
| 77 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.35830505 |
| 78 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.35141834 |
| 79 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.34910742 |
| 80 | Focal adhesion_Homo sapiens_hsa04510 | 0.33416304 |
| 81 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.29425395 |
| 82 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.28948568 |
| 83 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.28001384 |
| 84 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.27490289 |
| 85 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.25582614 |
| 86 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.25402950 |
| 87 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.24678865 |
| 88 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.24092137 |
| 89 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.23989466 |
| 90 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.23116693 |
| 91 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.22864331 |
| 92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.21036991 |
| 93 | Histidine metabolism_Homo sapiens_hsa00340 | 0.20516291 |
| 94 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.18142902 |
| 95 | Circadian entrainment_Homo sapiens_hsa04713 | 0.16854728 |
| 96 | GABAergic synapse_Homo sapiens_hsa04727 | 0.16636451 |
| 97 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.15950482 |
| 98 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.14755596 |
| 99 | Amoebiasis_Homo sapiens_hsa05146 | 0.14512735 |
| 100 | Insulin secretion_Homo sapiens_hsa04911 | 0.13819409 |

